The Influence of Blood on In Vivo Adenovirus Bio-distribution and Transduction

Wang, 2003, Systemic dissemination of viral vectors during intratumoral injection, Mol Cancer Ther, 2, 1233 Hiltunen, 2000, Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods, FASEB J, 14, 2230, 10.1096/fj.00-0145com Huard, 1995, The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants, Gene Ther, 2, 107 Steiner, 2007, Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia, Pediatr Blood Cancer Oka, 2001, Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor, Circulation, 103, 1274, 10.1161/01.CIR.103.9.1274 Parks, 1996, A helper-dependent adenovirus vector system: removal of helper virus by cre-mediated excision of the viral packaging signal, Proc Natl Acad Sci USA, 93, 13565, 10.1073/pnas.93.24.13565 Shayakhmetov, 2002, Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases, Cancer Res, 62, 1063 Gaggar, 2003, CD46 is a cellular receptor for group B adenoviruses, Nat Med, 9, 1408, 10.1038/nm952 Shayakhmetov, 2004, Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors, J Virol, 78, 5368, 10.1128/JVI.78.10.5368-5381.2004 Stone, 2005, Development and assessment of human adenovirus type 11 as a gene transfer vector, J Virol, 79, 5090, 10.1128/JVI.79.8.5090-5104.2005 Gaggar, 2005, Localization of regions in CD46 that interact with adenovirus, J Virol, 79, 7503, 10.1128/JVI.79.12.7503-7513.2005 Segerman, 2003, Adenovirus type 11 uses CD46 as a cellular receptor, J Virol, 77, 9183, 10.1128/JVI.77.17.9183-9191.2003 Nicklin, 2005, The influence of adenovirus fiber structure and function on vector development for gene therapy, Mol Ther, 12, 384, 10.1016/j.ymthe.2005.05.008 Reynolds, 2001, Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo, Nat Biotechnol, 19, 838, 10.1038/nbt0901-838 Reynolds, 2000, A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo, Mol Ther, 2, 562, 10.1006/mthe.2000.0205 Lyons, 2006, Adenovirus type 5 interactions with human blood cells may compromise systemic delivery, Mol Ther, 14, 118, 10.1016/j.ymthe.2006.01.003 Leopold, 2006, Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway, J Virol, 80, 10237, 10.1128/JVI.00512-06 Cotter, 2005, Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1, J Virol, 79, 14622, 10.1128/JVI.79.23.14622-14631.2005 Eggerman, 2002, Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation, Hum Gene Ther, 13, 125, 10.1089/10430340152712674 Othman, 2006, Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance, Blood, 109, 2832, 10.1182/blood-2006-06-032524 Stone, 2007, Adenovirus-platelet interaction in blood causes virus sequestration to the reticulo-endothelial system of liver, J Virol, 81, 4866, 10.1128/JVI.02819-06 Stone, 2005, Development and assessment of human adenovirus type 11 as a gene transfer vector, J Virol, 79, 5090, 10.1128/JVI.79.8.5090-5104.2005 Stone, 2005, Trapping of adenovirus vectors in blood, Mol Ther, 11, 159, 10.1016/j.ymthe.2005.06.414 Stone, 2006, Intravascular interaction between adenovirus and platelets promotes adenovirus sequestration, degradation and toxicity, Mol Ther, 13, S30, 10.1016/j.ymthe.2006.08.089 Nicol, 2004, Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats, Mol Ther, 10, 343, 10.1016/j.ymthe.2004.05.020 Smith, 2003, Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice, Hum Gene Ther, 14, 777, 10.1089/104303403765255165 Smith, 2003, Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates, Hum Gene Ther, 14, 1595, 10.1089/104303403322542248 Dechecchi, 2001, Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5, J Virol, 75, 8772, 10.1128/JVI.75.18.8772-8780.2001 Dechecchi, 2000, Heparan sulphate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions, Virology, 268, 382, 10.1006/viro.1999.0171 Bayo-Puxan, 2006, Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting, J Gen Virol, 87, 2487, 10.1099/vir.0.81889-0 Kritz, 2007, Adenovirus 5 fibers mutated at the KKTK putative HSPG binding site show restricted retargeting capacity when engineered with targeting peptides in the HI loop, Mol Ther, 15, 741, 10.1038/sj.mt.6300094 Shayakhmetov, 2005, Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity, J Virol, 79, 7478, 10.1128/JVI.79.12.7478-7491.2005 Gomez, 2006, Tissue factor initiated blood coagulation, Front Biosci, 11, 1349, 10.2741/1888 Davidson, 2003, 450 million years of hemostasis, J Thromb Haemost, 1, 1487, 10.1046/j.1538-7836.2003.00334.x Davidson, 2003, Molecular evolution of the vertebrate blood coagulation network, Thromb Haemost, 89, 420, 10.1055/s-0037-1613369 Parker, 2006, Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes, Blood, 108, 2554, 10.1182/blood-2006-04-008532 Zivelin, 1993, Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors, J Clin Invest, 92, 2131, 10.1172/JCI116814 Parker, 2007, Influence of coagulation factor zymogens on the Infectivity of adenoviruses pseudotyped with fibers from subgroup D, J Virol, 81, 3627, 10.1128/JVI.02786-06 Jiang, 2004, Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies, Mol Ther, 10, 1140, 10.1016/j.ymthe.2004.08.015 Zinn, 2004, Bioluminescence imaging reveals a significant role for complement in liver transduction following intravenous delivery of adenovirus, Gene Ther, 11, 1482, 10.1038/sj.gt.3302331 Kiang, 2006, Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system, Mol Ther, 14, 588, 10.1016/j.ymthe.2006.03.024 Sakurai, 2003, Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector, Mol Ther, 8, 813, 10.1016/S1525-0016(03)00243-0 Reddy, 2003, Development of adenovirus serotype 35 as a gene transfer vector, Virology, 311, 384, 10.1016/S0042-6822(03)00161-2 Sakurai, 2006, Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice, Gene Ther, 13, 1118, 10.1038/sj.gt.3302749 Shayakhmetov, 2005, Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors, J Immunol, 174, 7310, 10.4049/jimmunol.174.11.7310 Inoue, 2003, Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm, Mol Cell Biol, 23, 2614, 10.1128/MCB.23.7.2614-2622.2003 Cichon, 2003, Titer determination of Ad5 in blood: a cautionary note, Gene Ther, 10, 1012, 10.1038/sj.gt.3301961 Cho, 1991, Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassay, Clin Exp Immunol, 83, 257, 10.1111/j.1365-2249.1991.tb05624.x